Cipher Capital’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
Other funds holding DGX
Cipher Capital's DGX Position: Q3 2022 in Review
Cipher Capital sold out of Quest Diagnostics (DGX) in Q3 2022, closing a stake of 11,464 shares — an estimated $1.52M sold.
Cipher Capital first reported a position in DGX in Q1 2015 and held it in 15 quarters. The position peaked at $10.4M in Q4 2016. 808 funds tracked by Wall St. Rank hold DGX as of Q3 2022.
- Cipher Capital reported no remaining Quest Diagnostics position as of Q3 2022 after selling out during the quarter.
- Cipher Capital sold 11,464 Quest Diagnostics shares in Q3 2022, an estimated $1.52M.
- Cipher Capital first reported a position in Quest Diagnostics in Q1 2015 and held it in 15 quarters.
- Cipher Capital's Quest Diagnostics position peaked at $10.4M in Q4 2016.
- 808 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2022.
Based on Cipher Capital's 13F filing for Q3 2022, filed 14 Nov 2022.